ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,342,000 | -19.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,891,000 | -9.6% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,199,000 | -49.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,278,000 | -45.1% | 11,206 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $11,430,000 | -25.0% | 11,206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $19,050,000 | +37.1% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $13,895,000 | -12.7% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,913,000 | +17.4% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $13,559,000 | +17.5% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,542,000 | -39.1% | 11,206 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,938,000 | – | 11,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |